Ligand validation:3GN1

AX7: 1H-benzimidazol-2-amine

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3GN1_AX7_D_270	61%	57%	0.112	0.899	1.04	0.48	1	-	0	0	100%	1
3GN1_AX7_A_271	49%	55%	0.109	0.854	1.21	0.43	1	-	0	0	100%	1
3GN1_AX7_C_271	46%	55%	0.106	0.838	1.05	0.57	-	-	0	0	100%	1
2FPZ_AX7_B_1001	100%	34%	0.023	0.994	1.9	0.66	3	-	0	0	100%	1
3KQS_AX7_B_290	95%	4%	0.058	0.971	5.32	0.53	8	-	0	0	100%	1
5Z9B_AX7_A_304	85%	49%	0.084	0.955	1.03	0.86	1	-	0	0	100%	1
7DQH_AX7_A_301	85%	51%	0.105	0.977	0.92	0.86	-	-	0	0	100%	1
5PAR_AX7_C_506	83%	44%	0.096	0.961	1.31	0.77	1	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.